FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreState lawmakers are pursuing a wide range of artificial intelligence (AI) proposals that broadly fall into three themes: restrictions on AI use in prior authorization or claims processing; healthcare-specific guardrails for clinical AI tools; and broader transparency and privacy requirements for AI-driven consumer communications and data practices.
ACR® draws attention to a major trend in state legislatures to mandate human review of insurance coverage denials and prohibit determinations made solely by AI. Seven bills are under consideration in five states:
ACR also notes several states are considering measures related to governance and accountability for AI used in care delivery.
ACR’s State Government Relations Committee is available to assist state societies considering advancing legislation related to AI in healthcare. For more information or if you have questions, contact Eugenia Brandt, ACR Senior Government Relations Director.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more